Clinical trial Recruiting at 1 site Interventional Ages 18 and up Men only

Using COX-2 inhibitors to prevent urethral stricture recurrence after surgery

Official title: Can COX-2 Inhibitor Decrease Stricture Recurrence After Direct Vision Internal Urethrotomy?

Run by New Valley University · NCT06697106 · Data updated 2026-11-12

This study is testing if a medication called meloxicam can help prevent urethral strictures from coming back after surgery in people who have had these strictures for unknown reasons or due to previous medical treatments.

Quick facts

Study typeInterventional
Ages18 Years and up
SexMen only
Enrollment82 (estimated)
SponsorNew Valley University
Academic / other
Locations1 site (New Valley, New Valley Governorate)
StatusRecruiting
StartedNovember 20, 2024
Main results expectedApril 1, 2025
Study endsApril 1, 2025
Registry record updatedNovember 21, 2024
Trial IDNCT06697106 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older with a urethral stricture length of 1.5 cm or less and an ASA score of 3 or lower.

Probably not a fit

Patients with recurrent urethral strictures occurring two or more times or those with pelvic fracture urethral distraction defects may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness and safety of COX-2 inhibitors, specifically meloxicam, in reducing the recurrence of urethral strictures following direct vision internal urethrotomy. It focuses on patients with idiopathic or iatrogenic urethral strictures and aims to determine if administering NSAIDs can lead to better long-term outcomes. The study will compare outcomes between those receiving the medication and those given a placebo. Participants will be monitored for stricture recurrence over a specified follow-up period.

Why it matters

Potential benefit: If successful, this approach could significantly reduce the recurrence of urethral strictures, improving patient quality of life and reducing the need for additional surgeries.

How similar studies have gone: Previous studies have shown promising results with COX-2 inhibitors in similar contexts, indicating potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥ 18 years
* American Society of Anesthesiologists (ASA) score ≤3.
* Urethral stricture length ≤ 1.5 cm

Exclusion Criteria:

* Recurrent urethral stricture ≥ 2 times.
* Pelvic fracture urethral distraction defect (PFUDD).

Where it's running

  • New Valley University
    New Valley, New Valley Governorate, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.